Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marcocci

Showing results (171-180 of 199) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized studyC Marcocci, L Bartalena, M L Tanda, et al.
La Radiologia Medica|August 4, 2007
Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidismS Mazzeo, C Cappelli, D Caramella, et al.
Journal of Endocrinological Investigation|October 12, 2021
Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control studyL Mazoni, A Matrone, M Apicella, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidismF Cetani, A Picone, P Cerrai, et al.
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
The New England Journal of Medicine|January 8, 1998
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathyL Bartalena, C Marcocci, F Bogazzi, et al.
Journal of Endocrinological Investigation|June 26, 2020
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves' Disease: results of a pilot studyG Lanzolla, D Ricci, F Nicolì, et al.
Journal of Endocrinological Investigation|September 1, 2017
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patientsM Leo, E Sabini, I Ionni, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 8, 2003
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)M Pedrazzoni, G Girasole, F Bertoldo, et al.
Journal of Endocrinological Investigation|October 14, 2016
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trialM Leo, L Bartalena, G Rotondo Dottore, et al.
Pageof 20

Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|August 15, 2001
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized studyC Marcocci, L Bartalena, M L Tanda, et al.
La Radiologia Medica|August 4, 2007
Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidismS Mazzeo, C Cappelli, D Caramella, et al.
Journal of Endocrinological Investigation|October 12, 2021
Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control studyL Mazoni, A Matrone, M Apicella, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2001
Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidismF Cetani, A Picone, P Cerrai, et al.
Journal of Endocrinological Investigation|July 29, 2016
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathyE Sabini, E Sisti, B Coco, et al.
The New England Journal of Medicine|January 8, 1998
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathyL Bartalena, C Marcocci, F Bogazzi, et al.
Journal of Endocrinological Investigation|June 26, 2020
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves' Disease: results of a pilot studyG Lanzolla, D Ricci, F Nicolì, et al.
Journal of Endocrinological Investigation|September 1, 2017
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patientsM Leo, E Sabini, I Ionni, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 8, 2003
Definition of a population-specific DXA reference standard in Italian women: the Densitometric Italian Normative Study (DINS)M Pedrazzoni, G Girasole, F Bertoldo, et al.
Journal of Endocrinological Investigation|October 14, 2016
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trialM Leo, L Bartalena, G Rotondo Dottore, et al.
Pageof 20